Alan W. Katz, M.D., M.P.H.

Associate Professor of Radiation Oncology
University of Rochester Medical Center
M.P.H., University of Rochester School of Medicine and Dentistry, 2004
M.D., Sackler School of Medicine, Tel Aviv University, 1985

Clinical Specialty
Research Overview
Selected Honors
Education
Academic Appointments
Hospital Appointments
Publications

Clinical Specialty

Dr. Katz is responsible for radiation therapy of gastrointestinal malignancies, breast cancer, and many non-malignant conditions such as heterotopic bone and keloids.

Dr. Katz earned his MD from the Sackler School of Medicine, Tel Aviv University in Israel and did a fellowship in the Department of Radiation Oncology at the University of Rochester Medical Center from 1991-1992. After completing the fellowship, he returned to Israel and was an attending radiation oncologist at the Rabin Medical Center, Petach Tikva. Dr. Katz returned to the University of Rochester in 2001. He received his Masters of Public Health (MPH) in 2004 though the Radiology Cancer Research Training Curriculum, with a thesis titled Correlation of Interleukin- 6 and Interferon Gamma with Fatigue in Breast Cancer Patients Treated with Chemotherapy.

Dr. Katz specializes in gastrointestinal malignancies and breast cancer. . His clinical work and research has made him an expert on stereotactic body radiation therapy for primary and metastatic liver tumors. He has been involved in clinical trial development within the James P. Wilmot Cancer Center and through the Radiation Therapy Oncology Group. Certifications: Oncology, Israel Medical Association Scientific Council, Radiation Oncology, American Board of Radiology

Research Overview

Dr. Katz actively participates in several James P. Wilmot Cancer Center protocols investigating the use of stereotactic body radiation therapy. He was a principal investigator on the Radiation Therapy Oncology Group 0438 protocol, a multi-institutional study to evaluate the use of stereotactic body radiation therapy in patients with metastatic liver cancer.

Selected Honors

2008 American Medical Association Physician?s Recognition Award
2005 Department of Radiation Oncology Cassarett Award.
1991-1992: American Cancer Society Clinical Oncology Fellow

Education

2004 M.P.H., University of Rochester School of Medicine and Dentistry, Rochester, NY
1985 M.D. Sackler School of Medicine, Tel-Aviv University, Tel-Aviv Israel
1981 B.S. Biology, State University of New York at Binghamton, Binghamton, New York

Academic Appointments

2/2009-Present Associate Professor of Radiation Oncology
7/2004-1/2009 Assistant Professor of Radiation Oncology
8/2001-6/2004 Instructor in Clinical Radiation Oncology University of Rochester School of Medicine and Dentistry Rochester, New York
10/1997-7/2001 Instructor in Oncology, Sackler Faculty of Medicine Tel-Aviv University, Tel-Aviv, Israel
7/1991-6/1992 Instructor and Fellow in Radiation Oncology University of Rochester School of Medicine and Dentistry Rochester, New York

Hospital Appointments

1/09 - Present	Medical Director, Department of Radiation Oncology, University of Rochester Medical Center
8/01 - Present	Attending Radiation Oncologist, University of Rochester Strong Memorial Hospital Rochester, New York
9/95 - 7/01	Senior Radiation Oncologist Rabin Medical Center - Beilinson Campus Petach-Tikva, Israel
3/94 - 8/95	Senior Oncologist, Rabin Medical Center- Golda Campus, Petach-Tikva, Israel
7/91 - 6/92	Assistant Attending Radiation Oncologist University of Rochester Strong Memorial Hospital Rochester, New York

Publications

Brenner B, Rakowsky E, Katz A, Gutman H, Sulkes A, Schacter J, Fenig E.
Tailoring treatment for classical Kaposi's sarcoma: Comprehensive clinical guidelines.
Int J Oncol 1999;14:1097-1102.
Katz A, Brenner B, Sulkes A, Luria H, Marshak G, Fenig E.
Breast cancer in women following mantle field irradiation for Hodgkin's disease.
Harefuah 2000; 138(10):823-825.
Figer A, Brenner B, Katz A, Njuguna E, Sulkes A.
Case report: Umbilical metastasis of gallbladder carcinoma unrelated to a laparoscopic procedure.
Dig Dis and Sci 2000; 45(6):1058-1060.
Fenig E, Brenner B, Katz A, Sulkes J, Lapidot M, Schacter J, Malik H, Sulkes A, Gutman H.
Topical biafine and lipiderm for the prevention of radiation dermatitis: A randomized prospective trial.
Oncology Reports 2001; 8:305-309.
Kramer MR, Katz A, Yarmolovsky A, Schifter D, Fenig E.
Successful use of high dose rate brachytherapy for non-malignant bronchial obstruction.
Thorax 2001; 56: 415-416.
Katz A, Njuguna E, Rakowsky E, Sulkes J, Fenig E.
Early development of vaginal shortening during radiation therapy for endometrial or cervical cancer.
Int J Gynecol Cancer 2001; 11:234-235.
Katz A.
Correlation of interleukin-6 and interferon gamma with fatigue in breast cancer patients treated with chemotherapy (MPH thesis).
University of Rochester; 2004.
Rubin P, Brassachio R, Katz A.
Solitary Metastases: illusion versus reality.
Semin Radiat Oncol 2006;16:120-130
Katz AW, Carey-Sampson M, Muhs A, Milano MT, Schell MC, Okunieff P.
Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases.
Int J Radiat Oncol Biol Phys 2007; 67:793-798
Milano MT, Katz AW, Muhs AG, Philip A, Buchholtz DJ, Schell MC, Okunieff P.
A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions.
Cancer 2008;112:650-658 Chawla S, Chen Y, Katz AW, Muhs AG, Philip A, Okunieff P, Milano MT.
Stereotactic Body Radiotherapy for treatment of adrenal metastases.
Int J Radiat Oncol Biol Phys 2009;75:71-75
Fuller CD, Duppen J, Rasch CRN, Kachnic L, Wang SJ, Chang D, Goodman KA, Katz AW, Okunieff P, Thomas CR, et al.
A prospective randomized pilot study of site-specific atlas incorporation into target volume delineation instructions in the cooperative group setting: Preliminary results from a Southwest Oncology Group pilot using Big Brother[Abstract].
Int J Radiat Oncol Biol Phys 2009;75:S136-137